Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19
Article
[키워드] adverse effect
animal models
antibody
Antibody titer
BALB/c mice
changes in
class
COVID-19
COVID-19 vaccine
demonstrated
did not produce
ELISA
ENhance
enzyme-linked immunosorbent
ferrets
Gender
general condition
GMT
group
growth
hamster
hamsters
Health
histology
immune response
immunization
immunogenicity
Inactivated vaccine
injection
internal organ
Kazakhstan
lowest
microneutralization
MNA
nontoxic
preclinical trials
rhesus macaque
Safety
significant difference
statistically significant
Toxicity
Vaccine
were assessed
[DOI] 10.1080/21645515.2022.2087412 PMC 바로가기
[DOI] 10.1080/21645515.2022.2087412 PMC 바로가기